Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector
Sponsor: Boehringer Ingelheim
Summary
The goal of this study is to find out whether different formulations of survodutide given by different delivery methods is taken up in the body in a similar way. Participants visit the study site regularly. During study visits, the doctors collect information about participants' health. To assess the study endpoints, participants regularly have blood samples taken.
Official title: Bioequivalence of Survodutide (BI 456906) When Administered Via Pre-filled Syringe (Formulation A) and Pre Filled Pen (Formulation B2) in Male and Female Trial Participants Who Are Healthy or Otherwise Healthy With Overweight/Obesity (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Trial)
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
56
Start Date
2026-03-03
Completion Date
2026-06-08
Last Updated
2026-03-05
Healthy Volunteers
Yes
Interventions
Survodutide formulation A
Pre-filled syringe
Survodutide formulation B2
Pre-filled pen
Locations (1)
Humanpharmakologisches Zentrum Biberach
Biberach, Germany